The design of multi-target ligands and their role in schizophrenia therapy: an update

  • Published on 06/02/2026
  •  Reading time: 1 min.

Zarko Gagic a,* , Marija Popovic-Nikolic b , Marija Carapic c , Selma Zukic d , Slavica Oljacic b & Katarina Nikolic b,*

a Department of Pharmaceutical Chemistry, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
b Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
c Pharmaceutical Department - Human Medicines Center, Medicines and Medical Devices Agency of Serbia, Belgrade, Serbia
d Institute of Chemistry, University of Tartu, Tartu, Estonia

CONTACT Zarko Gagic mailto:zarko.gagic@med.unibl.org Department of Pharmaceutical Chemistry, Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, Banja Luka 78000, Bosnia and Herzegovina
Katarina Nikolic mailto:katarina.nikolic@pharmacy.bg.ac.rs Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, Belgrade 11000, Serbia

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Psychiatry

Receive our newsletter to stay up to date with the latest news in Psychiatry

More articles

From peer-reviewed journals in Psychiatry